Home » Topics » BioWorld Science

BioWorld Science
RSS

Triple kinase inhibitor IBL-302 shows promising activity in preclinical models of neuroblastoma

Aug. 16, 2019

Fast skeletal muscle troponin activators can counter skeletal muscle fatigue

Aug. 16, 2019

Adropin is correlated with erectile dysfunction in coronary artery disease patients

Aug. 16, 2019

IL-13Rlalpha2 as a therapeutic target in inflammatory bowel disease

Aug. 16, 2019

TNFR2 is yang to TNFR1's yin

Aug. 16, 2019

FDA clears Heat Biologics' IND for study of HS-130 plus HS-110

Aug. 14, 2019

Too much oxygen may be issue in Leigh syndrome

Aug. 14, 2019

European Commission approves ibrutinib for expanded use in two indications

Aug. 14, 2019

Enrollment ongoing in phase III study of tucatinib plus T-DM1 in HER2+ breast cancer

Aug. 14, 2019

DelMar reports updated results from phase II study of VAL-083 in newly diagnosed GBM

Aug. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads
BioWorld
Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...